Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 7, 2015, Pages 10875-10884

  Yan, Wenwen ^a   Wang, Lemin ^a   Jiang, Jinfa ^a   Xu, Wenjun ^a   Gong, Zhu ^a   Duan, Qianglin ^a   Li, Chuanrong ^a   Song, Haoming ^a   Che, Lin ^a   Shen, Yuqin ^a   Zhou, Lin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cellular immunity; Gene expression; Myocardial infarction; Stable angina pectoris; T cell

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ACUTE HEART INFARCTION; ADULT; ANTIGEN RECOGNITION; ARTICLE; B7 H2 GENE; CASP8 GENE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; FYN GENE; GENE; GENE EXPRESSION; GZMK GENE; GZMM GENE; HUMAN; ICOS GENE; LAT GENE; LCK GENE; MALE; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRF1 GENE; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE ANGINA PECTORIS; T LYMPHOCYTE; TCRA GENE; TCRG GENE; TCRZ GENE; TH1 CELL; TH17 CELL; TH2 CELL; TRB GENE;

EID: 84940652053     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
2. van Dijk RA, Duinisveld AJ, Schaapherder AF, Mulder-Stapel A, Hamming JF, Kuiper J, de Boer OJ, van der Wal AC, Kolodgie FD, Virmani R, Lindeman JH. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis. J Am Heart Assoc 2015; 4.
3. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26: 2421-2432.
4. Businaro R, Tagliani A, Buttari B, Profumo E, Ippoliti F, Di Cristofano C, Capoano R, Salvati B, Riganò R. Cellular and molecular players in the atherosclerotic plaque progression. Ann N Y Acad Sci 2012; 1262: 134-141.
5. Grivel JC, Ivanova O, Pinegina N, Blank PS, Shpektor A, Margolis LB, Vasilieva E. Activation of T lymphocytes in atherosclerotic plaques.Arterioscler Thromb Vasc Biol 2011; 31: 2929-2937.
6. Dave T, Ezhilan J, Vasnawala H, Somani V. Plaque regression and plaque stabilisation in cardiovascular diseases. Indian J Endocrinol Metab 2013; 17: 983-989.
7. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, Li P, Tipping P, Bobik A, Toh BH. Cytotoxic and proinflammatory CD8+T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation 2013; 127: 1028-1039.
8. Ni M, Chen WQ, Zhang Y. Animal models and potential mechanisms of plaque destabilisation and disruption. Heart 2009; 95: 1393-1398.
9. Johnson JL, Jackson CL. Atherosclerotic pla-que rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001; 154: 399-406.
10. Ma T, Gao Q, Zhu F, Guo C, Wang Q, Gao F, Zhang L. Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice. Cell Mol Immunol 2013; 10: 338-348.
11. Zhou J, Dimayuga PC, Zhao X, Yano J, Lio WM, Trinidad P, Honjo T, Cercek B, Shah PK, Chyu KY. CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-/-) mice. Biochem Biophys Res Commun 2014; 443: 864-70.
12. Mor A, Luboshits G, Planer D, Keren G, George J. Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndro-mes. Eur Heart J 2006; 27: 2530-2537.
13. Li Q, Wang Y, Wang Y, Chen K, Zhou Q, Wei W, Wang Y. Treg/Th17 ratio acts as a novel indicator for acute coronary syndrome. Cell Biochem Biophys 2014; 70: 1489-1498.
14. Zhang L, Wang T, Wang XQ, Du RZ, Zhang KN, Liu XG, Ma DX, Yu S, Su GH, Li ZH, Guan YQ, Du NL. Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome. PLoS One 2013; 8: e71466.
15. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B. The complex role of T-cell-based immunity in atherosclerosis. Curr Atheroscler Rep 2008; 10: 236-243.
16. Matusik P, Guzik B, Weber C, Guzik TJ. Do we know enough about the immune pathogene-sis of acute coronary syndromes to improve clinical practice? Thromb Haemost 2012; 108: 443-456.
17. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials & Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials & Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials & Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials & Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guide lines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-98.
18. Guy CS, Vignali DA. Organization of proximal signal initiation at the TCR: CD3 complex. Immunol Rev 2009; 232: 7-21.
19. Zehn D, King C, Bevan MJ, Palmer E. TCR signaling requirements for activating T cells and for generating memory. Cell Mol Life Sci 2012; 69: 1565-1575.
20. König R. Interactions between MHC molecules and co-receptors of the TCR. Curr Opin Immunol 2002; 14: 75-83.
21. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005; 105: 13-21.
22. Hansen JD, Pasquier LD, Lefranc MP, Lopez V, Benmansour A, Boudinot P. The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective. Mol Immunol 2009; 46: 457-472.
23. Howland KC, Ausubel LJ, London CA, Abbas AK. The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol 2000; 164: 4465-4470.
24. Sigrid SS, Kristine M, Torunn B, Aandahl EM, Taskén K. T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses. Biochem J 2014; 460: 399-410.
25. Lin H, Martelli MP, Bierer BE. The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. Int Immunol 2001; 13: 13-22.
26. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009; 228: 9-22.
27. Palacios EH, Weiss A. Function of the Src-fa-mily kinases, Lck and Fyn, in T-cell developme-nt and activation. Oncogene 2004; 23: 7990-8000.
28. Thome M. Multifunctional roles for MALT1 in T-cell activation. Nat Rev Immunol 2008; 8: 495-500.
29. Bartelt RR, Houtman JCD. The adaptor protein LAT serves as an integration node for signaling pathways that drive T cell activation. Wiley Interdiscip Rev Syst Biol Med 2013; 5: 101-110.
30. Gadhamsetty S, Marée AFM, Beltman JB, de Boer RJ. A General Functional Response of Cytotoxic T Lymphocyte-Mediated Killing of Target Cells. Biophys J 2014; 106: 1780-1791.
31. Keefe D, Shi L, Feske S, Massol R, Navarro F, Kirchhausen T, Lieberman J. Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 2005; 23: 249-262.
32. Berke G. The CTL's kiss of death. Cell 1995; 81: 9-12.
33. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15: 297-322.
34. Vanaki E, Ataei M, Sanati MH, Mansouri P, Mahmoudi M, Zarei F, Jadali Z. Expression patterns of Th1/Th2 transcription factors in patients with guttate psoriasis. Acta Microbiol Immunol Hung 2013; 60: 163-174.
35. Gao P, Zhou XY, Yashiro-Ohtani Y, Yang YF, Sugimoto N, Ono S, Nakanishi T, Obika S, Imanishi T, Egawa T, Nagasawa T, Fujiwara H, Hamaoka T. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blo-ckade of two Th1 chemokine receptors CCR5 and CXCR3. J Leukoc Biol 2003; 73: 273-280.
36. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344-345.
37. Wan YY. GATA3: a master of many trades in immune regulation. Trends Immunol 2014; 35: 233-242.
38. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-2007.
39. Nagata K, Hirai H. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 169-77.
40. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, Aleksza M, Nakken B, Szegedi G, Soltesz P. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006; 64: 336-344.
41. Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, Wang M, Liu Y, Guo Z, Chen J, Zhang J, Zhang L.TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflam mation or myocardial inflammation. J Clin Immunol 2005; 25: 246-253.
42. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, Sokol SI, Pfau S, Pober JS, Tellides G. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009; 119: 1424-1432.
43. Zuniga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev 2013; 252: 78-88.
44. Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010; 21: 443-448.
45. Unutmaz D. RORC2: the master of human Th17 cell programming. Eur J Immunol 2009; 39: 1452-1455.
46. Wang C, Kang SG, Lee J, Sun Z, Kim CH. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2009; 2: 173-183.
47. Moriguchi K, Miyamoto K, Tanaka N, Yoshie O, Kusunoki S. The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2013; 257: 53-58.
48. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6: 338-344.
49. Klein S, Kretz CC, Krammer PH, Kuhn A. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol 2010; 130: 492-9.
50. Hall BM, Verma ND, Tran GT, Hodgkinson SJ.Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells. Curr Opin Immunol 2011; 23: 641-647.
51. Ephrem A, Epstein AL, Stephens GL, Thornton AM, Glass D, Shevach EM. Modulation of Treg cells/T effector function by GITR signaling is context-dependent. Eur J Immunol 2013; 43: 2421-2429.
52. Caridade M, Graca L, Ribeiro RM. Mechanisms underlying CD4+ Treg immune regulation in the adult: from experiments to models. Front Immunol 2013; 4: 387.
53. Potekhina AV, Pylaeva E, Provatorov S, Ruleva N, Masenko, Noeva E, Krasnikova T, Arefieva T. Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis. Atherosclerosis2015; 238: 17-21.
54. Ammirati E, Cianflone D, Banfi M, Vecchio V, Palini A, De Metrio M, Marenzi G, Panciroli C, Tumminello G, Anzuini A, Palloshi A, Grigore L, Garlaschelli K, Tramontana S, Tavano D, Airoldi F, Manfredi AA, Catapano AL, Norata GD. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 1832-1841.